20/20 Biolabs, Inc. (AIDX) Gross Margin (2025 - 2026)
20 (AIDX) recorded Gross Margin of 41.71% in Q2 2026, up 11.20 percentage points from 30.51% a year earlier and up 23.92 percentage points from the prior quarter.
Powered by 
Analysis
20/20 Biolabs, Inc. (AIDX) Gross Margin (2025 - 2026) Analysis & Trends
On a TTM basis, 20's Gross Margin came in at 32.06% as of Jun 30, 2026; for FY2025, it came in at 29.56%, up 9.00 percentage points from FY2024.
- Across earlier years, Gross Margin came in at 20.56% in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.71% |
| Mar 31, 2026 | 17.80% |
| Jun 30, 2025 | 30.51% |
| Mar 31, 2025 | 29.94% |
API Access
20/20 Biolabs, Inc. Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AIDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AIDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AIDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();